Correspondence 0001213900-23-042708 from MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099) (MESO)
MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099)
Date: May 24, 2023 · CIK: 0001345099 · Accession: 0001213900-23-042708
AI Filing Summary & Sentiment
File numbers found in text: 333-272029
Letter
Mesoblast Limited
Level 38, 55 Collins Street
Melbourne, VIC 3000
Australia
May 24, 2023
via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, DC 20549
RE: Mesoblast Limited
Registration Statement on Form F-3
Filed: May 18, 2023
Securities Act File No. : 333-272029
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, Mesoblast Limited (the “Registrant”) hereby respectfully requests acceleration of its Registration Statement on Form F-3 (File No. 333-272029), filed on May 18, 2023, so that it will become effective at 9:00 a.m. (Eastern time) on May 26, 2023, or as soon as practicable thereafter.
If you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant’s outside counsel, at andrew.reilly@rimonlaw.com.
The Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority) (the “Commission”) declares the filing effective, such action:
(i) does not foreclose the Commission from taking any action with respect to the filing;
(ii) does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii) may not be asserted by the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
Mesoblast Limited
Show Raw Text
CORRESP
1
filename1.htm
Mesoblast
Limited
Level
38, 55 Collins Street
Melbourne,
VIC 3000
Australia
May
24, 2023
via
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
RE:
Mesoblast
Limited
Registration
Statement on Form F-3
Filed:
May 18, 2023
Securities
Act File No. : 333-272029
Request
for Acceleration of Effectiveness
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, Mesoblast Limited (the “Registrant”) hereby respectfully requests acceleration
of its Registration Statement on Form F-3 (File No. 333-272029), filed on May 18, 2023, so that it will
become effective at 9:00 a.m. (Eastern time) on May 26, 2023, or as soon as practicable thereafter.
If
you have any questions, or require any additional information, please do not hesitate to email Andrew Reilly, the Registrant’s
outside counsel, at andrew.reilly@rimonlaw.com.
The
Registrant hereby acknowledges that, if the Securities and Exchange Commission (or its staff, acting pursuant to delegated authority)
(the “Commission”) declares the filing effective, such action:
(i)
does not
foreclose the Commission from taking any action with respect to the filing;
(ii)
does not relieve the Registrant
from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(iii)
may not be asserted by
the Registrant as a defence in any proceeding initiated by the Commission or any person under the federal securities laws of the
United States.
Very truly yours,
Mesoblast Limited
By:
/s/
Andrew Chaponnel
Andrew Chaponnel
Interim Chief Financial
Officer